Multimodal Analgesia With Acetaminophen vs. Narcotics Alone After Hip Arthroscopy
Status: | Recruiting |
---|---|
Healthy: | No |
Age Range: | 18 - 65 |
Updated: | 4/29/2018 |
Start Date: | April 10, 2018 |
End Date: | April 2020 |
Contact: | Hien Pham |
Email: | Hien.Pham@nyumc.org |
Phone: | 212 348 3636 |
The purpose of this proposed study is to evaluate the efficacy of a multimodal approach to
analgesia for patient's pain after hip arthroscopy and to also assess if this new approach
will result in a reduction in post-operative narcotic use.
This study is a single-center, randomized prospective study comparing post-operative pain
scores and narcotic consumption between individuals receiving acetaminophen along with a
reduced quantity of Percocet (to be used as needed for breakthrough pain) and individuals
receiving Percocet only. Both pain management options are considered to be standard of care.
Both cohorts will receive aspirin for DVT prophylaxis and celecoxib for heterotopic
ossification prophylaxis.
The primary objective of the study are to compare patients' narcotic consumption and reported
pain following arthroscopic hip surgery, and determine if acetaminophen can provide adequate
pain relief compared to a narcotic medication.
analgesia for patient's pain after hip arthroscopy and to also assess if this new approach
will result in a reduction in post-operative narcotic use.
This study is a single-center, randomized prospective study comparing post-operative pain
scores and narcotic consumption between individuals receiving acetaminophen along with a
reduced quantity of Percocet (to be used as needed for breakthrough pain) and individuals
receiving Percocet only. Both pain management options are considered to be standard of care.
Both cohorts will receive aspirin for DVT prophylaxis and celecoxib for heterotopic
ossification prophylaxis.
The primary objective of the study are to compare patients' narcotic consumption and reported
pain following arthroscopic hip surgery, and determine if acetaminophen can provide adequate
pain relief compared to a narcotic medication.
Inclusion Criteria:
- ASA class I-II
- Patients indicated and scheduled for arthroscopic hip surgery
Exclusion Criteria:
- Contraindication to acetaminophen or oxycodone/acetaminophen (e.g. hypersensitivity,
history of GI or bleeding disorder)
- Legally incompetent or mentally impaired (e.g. minors, Alzheimer's subjects, dementia,
etc.)
- Younger than 18 years of age or older than 65
- Any patient considered a vulnerable subject
- Patients on pain medication prior to surgery
We found this trial at
1
site
550 1st Ave
New York, New York 10016
New York, New York 10016
(212) 263-7300
Principal Investigator: Thomas Youm, MD
Phone: 212-348-3636
New York University School of Medicine NYU School of Medicine has a proud history that...
Click here to add this to my saved trials